Pazdur R - Search Results

1

Pharmacokinetics of recombinant human interferon-alpha 2a combined with 5-fluorouracil in patients with advanced colorectal carcinoma.

Kim J, Zhi J, Satoh H, Koss-Twardy SG, Passe SM, Patel IH, Pazdur R. Kim J, et al. Among authors: pazdur r. Anticancer Drugs. 1998 Sep;9(8):689-96. doi: 10.1097/00001813-199809000-00004. Anticancer Drugs. 1998. PMID: 9823427 Clinical Trial.

2

Phase I trial of Taxotere: five-day schedule.

Pazdur R, Newman RA, Newman BM, Fuentes A, Benvenuto J, Bready B, Moore D Jr, Jaiyesimi I, Vreeland F, Bayssas MM, et al. Pazdur R, et al. J Natl Cancer Inst. 1992 Dec 2;84(23):1781-8. doi: 10.1093/jnci/84.23.1781. J Natl Cancer Inst. 1992. PMID: 1359154 Clinical Trial.

3

Clinical pharmacology of combined oral uracil and ftorafur.

Ho DH, Covington WP, Pazdur R, Brown NS, Kuritani J, Newman RA, Raber MN, Krakoff IH. Ho DH, et al. Among authors: pazdur r. Drug Metab Dispos. 1992 Nov-Dec;20(6):936-40. Drug Metab Dispos. 1992. PMID: 1362949 Clinical Trial.

4

Phase II trial of fazarabine in advanced colorectal carcinoma.

Hubbard KP, Daugherty K, Ajani JA, Pazdur R, Levin B, Abbruzzese JL. Hubbard KP, et al. Among authors: pazdur r. Invest New Drugs. 1992 Apr;10(1):39-42. doi: 10.1007/BF01275479. Invest New Drugs. 1992. PMID: 1376722 Clinical Trial.

5

Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.

Pazdur R, Ajani JJ, Abbruzzese JL, Belt RJ, Dakhil SR, Dubovsky D, Graham S, Pilat S, Winn R, Levin B. Pazdur R, et al. Cancer. 1992 Oct 15;70(8):2073-6. doi: 10.1002/1097-0142(19921015)70:8<2073::aid-cncr2820700810>3.0.co;2-a. Cancer. 1992. PMID: 1394037 Clinical Trial.

6

Phase I study of 5-fluorouracil with folinic acid combined with recombinant human granulocyte-macrophage colony-stimulating factor.

Moore DF Jr, Pazdur R. Moore DF Jr, et al. Among authors: pazdur r. Am J Clin Oncol. 1992 Dec;15(6):464-6. doi: 10.1097/00000421-199212000-00002. Am J Clin Oncol. 1992. PMID: 1449107 Clinical Trial.

7

Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer.

Hubbard KP, Pazdur R, Ajani JA, Braud E, Blaustein A, King M, Llenado-Lee M, Winn R, Levin B, Abbruzzese JL. Hubbard KP, et al. Among authors: pazdur r. Am J Clin Oncol. 1992 Dec;15(6):524-7. Am J Clin Oncol. 1992. PMID: 1449117 Clinical Trial.

8

Phase II study of gemcitabine in advanced colorectal adenocarcinoma.

Moore DF Jr, Pazdur R, Daugherty K, Tarassoff P, Abbruzzese JL. Moore DF Jr, et al. Among authors: pazdur r. Invest New Drugs. 1992 Nov;10(4):323-5. doi: 10.1007/BF00944189. Invest New Drugs. 1992. PMID: 1487408 Clinical Trial.

9

Modulation of fluorouracil with recombinant alfa interferon: M. D. Anderson Clinical trial.

Pazdur R, Moore DF Jr, Bready B. Pazdur R, et al. Semin Oncol. 1992 Apr;19(2 Suppl 3):176-9. Semin Oncol. 1992. PMID: 1557643 Clinical Trial.

10

A phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma.

Pazdur R, Ajani JA, Winn R, Bearden J, Belt RJ, Pilat S, Hallinan R, Levin B. Pazdur R, et al. Cancer. 1992 Feb 15;69(4):878-82. doi: 10.1002/1097-0142(19920215)69:4<878::aid-cncr2820690407>3.0.co;2-0. Cancer. 1992. PMID: 1735078 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

583 results

Search Page